134 related articles for article (PubMed ID: 2482548)
1. Alpha-2-macroglobulin is an important progressive inhibitor of thrombin in neonatal and infant plasma.
Schmidt B; Mitchell L; Ofosu FA; Andrew M
Thromb Haemost; 1989 Dec; 62(4):1074-7. PubMed ID: 2482548
[TBL] [Abstract][Full Text] [Related]
2. alpha 2-Macroglobulin remains as important as antithrombin III for thrombin regulation in cord plasma in the presence of endothelial cell surfaces.
Ling X; Delorme M; Berry L; Ofosu F; Mitchell L; Paes B; Andrew M
Pediatr Res; 1995 Mar; 37(3):373-8. PubMed ID: 7540283
[TBL] [Abstract][Full Text] [Related]
3. Alpha-2-macroglobulin may provide protection from thromboembolic events in antithrombin III-deficient children.
Mitchell L; Piovella F; Ofosu F; Andrew M
Blood; 1991 Nov; 78(9):2299-304. PubMed ID: 1718494
[TBL] [Abstract][Full Text] [Related]
4. Thrombin inhibition by fetal distal lung epithelium is different in fetal and adult plasma.
Andrew M; Berry L; O'Brodovich H
Am J Respir Cell Mol Biol; 1994 Jul; 11(1):35-41. PubMed ID: 7517142
[TBL] [Abstract][Full Text] [Related]
5. Anticoagulant effects of heparin in neonatal plasma.
Schmidt B; Ofosu FA; Mitchell L; Brooker LA; Andrew M
Pediatr Res; 1989 Apr; 25(4):405-8. PubMed ID: 2726317
[TBL] [Abstract][Full Text] [Related]
6. Fate of thrombin and thrombin-antithrombin-III complex adsorbed to a heparinized biomaterial: analysis of the enzyme-inhibitor complexes displaced by plasma.
Hatton MW; Rollason G; Sefton MV
Thromb Haemost; 1983 Dec; 50(4):873-7. PubMed ID: 6198746
[TBL] [Abstract][Full Text] [Related]
7. Respective roles of antithrombin III and alpha 2 macroglobulin in thrombin inactivation.
Fischer AM; Tapon-Bretaudiere J; Bros A; Josso F
Thromb Haemost; 1981 Feb; 45(1):51-4. PubMed ID: 6166063
[TBL] [Abstract][Full Text] [Related]
8. Decreased concentrations of heparinoids are required to inhibit thrombin generation in plasma from newborns and children compared to plasma from adults due to reduced thrombin potential.
Chan AK; Berry LR; Monagle PT; Andrew M
Thromb Haemost; 2002 Apr; 87(4):606-13. PubMed ID: 12008942
[TBL] [Abstract][Full Text] [Related]
9. Thrombin inhibition is impaired in plasma of sick neonates.
Shah JK; Mitchell LG; Paes B; Ofosu FA; Schmidt B; Andrew M
Pediatr Res; 1992 Apr; 31(4 Pt 1):391-5. PubMed ID: 1373886
[TBL] [Abstract][Full Text] [Related]
10. Thrombin regulation in children differs from adults in the absence and presence of heparin.
Andrew M; Mitchell L; Vegh P; Ofosu F
Thromb Haemost; 1994 Dec; 72(6):836-42. PubMed ID: 7740451
[TBL] [Abstract][Full Text] [Related]
11. Formation of activated protein C and inactivation of cell-bound thrombin by antithrombin III at the surface of cultured vascular endothelial cells--a comparative study of two anticoagulant mechanisms.
Delvos U; Meusel P; Preissner KT; Müller-Berghaus G
Thromb Haemost; 1987 Feb; 57(1):87-91. PubMed ID: 3590084
[TBL] [Abstract][Full Text] [Related]
12. [Heparin inhibition of the antithrombin activity of alpha-2-macroglobulin].
Fischer AM; Bros A; Rafowicz S; Josso F
C R Seances Acad Sci D; 1979 Mar; 288(10):887-9. PubMed ID: 89015
[TBL] [Abstract][Full Text] [Related]
13. Clinical measures of heparin's effect and thrombin inhibitor levels in pediatric patients with congenital heart disease.
Guzzetta NA; Miller BE; Todd K; Szlam F; Moore RH; Brosius KK; Wilson EC; Cohen AM; Tosone SR
Anesth Analg; 2006 Nov; 103(5):1131-8. PubMed ID: 17056945
[TBL] [Abstract][Full Text] [Related]
14. The additive effect of low molecular weight heparins on thrombin inhibition by dermatan sulfate.
Cosmi B; Agnelli G; Young E; Hirsh J; Weitz J
Thromb Haemost; 1993 Sep; 70(3):443-7. PubMed ID: 8259546
[TBL] [Abstract][Full Text] [Related]
15. Concentrations of alpha 1-proteinase inhibitor and alpha 2-macroglobulin in serum and lung secretions of intubated infants.
Bruce MC; Martin RJ; Boat TF
Pediatr Res; 1984 Jan; 18(1):35-40. PubMed ID: 6199725
[TBL] [Abstract][Full Text] [Related]
16. [A study of antithrombin systems during heparin therapy].
Boneu B; Immaculato F; Sie P; Caranobe C; Chamontin B; Guittard J
Nouv Presse Med; 1982 Oct; 11(41):3043-6. PubMed ID: 6183640
[TBL] [Abstract][Full Text] [Related]
17. The effects of human thrombomodulin on the inactivation of thrombin by its serum inhibitors.
Thompson EA; Salem HH
Thromb Haemost; 1987 Oct; 58(3):806-10. PubMed ID: 2829375
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of plasma alpha-2-macroglobulin and interactions with tumour necrosis factor-alpha in horses with endotoxemic signs.
Coté N; Trout DR; Hayes AM
Can J Vet Res; 1996 Apr; 60(2):150-7. PubMed ID: 8785722
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of thrombin by antithrombin III and heparin cofactor II in vivo.
Liu L; Dewar L; Song Y; Kulczycky M; Blajchman MA; Fenton JW; Andrew M; Delorme M; Ginsberg J; Preissner KT
Thromb Haemost; 1995 Mar; 73(3):405-12. PubMed ID: 7545318
[TBL] [Abstract][Full Text] [Related]
20. Regulation of factor IXa in vitro in human and mouse plasma and in vivo in the mouse. Role of the endothelium and the plasma proteinase inhibitors.
Fuchs HE; Trapp HG; Griffith MJ; Roberts HR; Pizzo SV
J Clin Invest; 1984 Jun; 73(6):1696-703. PubMed ID: 6202716
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
